Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SolarSpring closes sales contract for an MD pilot system to be used in industrial water recycling project

Clean Industry Solutions’ subsidiary SolarSpring, a pioneer in the field of membrane distillation offering innovative waste- and drinking water treatment technology, has closed a sales contract for a membrane distillation pilot unit with a volume of 40,868.40 €. The unit was sold to Aquas Industriales de Tarragona S.A. and will be used for industrial wastewater recycling within the EU funded project ULTIMATE.Today, SolarSpring signed a sales contract with a volume of 40,868.40 €. The membrane distillation pilot unit will be delivered end of June, with 80 % of the total amount paid upfront

Transactions in connection with share buyback programme

Company announcement 10/2022 On 4 January 2022, HusCompagniet A/S (“HusCompagniet”) launched a share buyback programme, as described in Company Announcement No. 1/2022. According to the programme, HusCompagniet will in the period from 4 January 2022 to 31 March 2022 purchase own shares up to a maximum value of DKK 40 million and no more than 316,942 shares, corresponding to 1.6% of the share capital at commencement of the programme. The share buyback programme has been implemented in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the

SyntheticMR proposes election of new board member

The Nomination Committee of SyntheticMR has proposed to the Annual General Meeting 2022 that the Board will comprise five ordinary members without deputies. The proposed election of Ann-Christine Sundell will be in addition to the re-election of the current board members Staffan Persson, Petra Apell, Johan Sedihn, and Jan Bertus Marten Warntjes. Ann-Christine Sundell, born in 1964, has extensive experience from leading positions and board assignments in medtech and diagnostics, including global market expansion, product development and the establishment of national screening programs.

BioStock: Celebrating IND approval Abliva eyes next step with KL1333

The reporting season is in full swing and Swedish biotech Abliva recently published their fourth quarter results for 2021. Looking at the activities in the last quarter, the company focused on lead candidate KL1333 as it took a pivotal step towards the planned phase II/III-study by obtaining Investigational New Drug-approval from the FDA. BioStock spoke to CEO Ellen Donnelly about the past quarter and what lies ahead.Read the full article at biostock.se:https://www.biostock.se/en/2022/03/celebrating-ind-approval-abliva-eyes-next-step-with-kl1333/This is a press release from BioStock -

BPC Instruments presents at Aktiedagen Stockholm Monday 14[th] March 2022

BPC Instruments will present the Company, its latest financial figures, and the recent launch of its new flagship product – BPC[®] Go – at Aktiedagen Stockholm, 14 March 2022, at 08.00.On 14 March at 08.00 BPC Instruments will participate at Aktiedagen Stockholm. CEO Dr. Jing Liu will present the company and answer questions. We invite you as journalists, analysts and shareholders to follow the presentation live on the web, via www.aktiespararna.se/tv/live. The event is open to everyone and does not require membership in Aktiespararna. No registration is required to follow the event

SimCorp A/S – Share buyback program

Company Announcement no. 6/2022On February 15, 2022 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 15, 2022 to July 31, 2022. The following transactions have been executed under the program:          Date                 Number of shares

Asetek - Mandatory Notification of Trade: Board Member Purchases Shares

07 March 2022 - Board member and primary insider of Asetek A/S Jørgen Smidt has on Friday, March 4, 2022, purchased 42,600 shares in the open market at an average price of NOK 32.37 per share. Following the transaction, Jørgen Smidt owns 59,200 Asetek shares. About Asetek Asetek (ASTK.OL), a global leader in mechatronic innovation, is a Danish garage-to-stockexchange success story. Founded in 2000, Asetek established its innovative position as the leading OEM developer and producer of the all-in-one liquid cooler for all major PC &Enthusiast gaming brands. In 2013, Asetek went public

Aptahem reports prepared GMP certified Apta-1 for preparation of clinical studies

Aptahem announces today that the production of Good Manufacturing Practice (GMP) manufacturing of the drug candidate Apta-1 successfully has been prepared by the collaboration partner LGC Biotechnologies in the USA, according to timeplan. The GMP manufactured Apta-1 will be used in the future clinical studies.Aptahem’s partner LGC has improved the process parameters for the GMP production and with that obtained a more efficient CoG (Cost of Goods) which is an important part of creating an attractive partnering deal. The final delivery has met the company’s quality goals and also exceeded

Antti Haapala appointed as Professor of Wood Materials Science and Technology

Wood materials science is present in our daily life, even though we don’t always recognise it. Wood refining runs in some families. Following in the footsteps of his father, Professor of Wood Materials Science and Technology Antti Haapala entered the wood processing sector at the age of 16, when he started working in a UPM paper mill in Kajaani.“During my university years in Oulu, I spent more time at paper mills in Kajaani and Oulu than in the lecture rooms, but I did manage to complete my MSc in engineering in four years, after I found my own field and switched my major from computer

ASSA ABLOY publishes its Sustainability Report 2021

ASSA ABLOY, the global leader in access solutions, has today published its Sustainability Report 2021. In 2021, the Group made a very positive start against its targets in the sustainability program to 2025.   ASSA ABLOY has reduced the water intensity by 24%, waste intensity by 2% and organic solvent intensity by 48% since the 2019 base year. The reduction of absolute carbon emissions is well on plan with a decrease of 17% since 2019. The health and safety of employees is a priority, where the Group’s aim is to be an injury-free workplace. Through the roll-out of the health and

ASSA ABLOY publishes its Annual Report 2021

ASSA ABLOY, the global leader in access solutions, has today published its Annual Report 2021.  The report can be found on the Group’s website: www.assaabloy.com.   For more information, please contact: Björn Tibell, VP & Investor Relations, tel. no: +46 8 506 485 73Ann Holmberg, Group Communications, tel. no: +46 8 506 485 54   This information is information that ASSA ABLOY AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 09:30 CET on 7 March 2022. About ASSA ABLOY The ASSA ABLOY Group is the

Glycorex Transplantation AB (publ.) Announces Appointment of Head of Sales.

Lund, Sweden, March 7[th], 2022 – Glycorex Transplantation AB, a commercial stage medical device company, today announces Mr. Erik Melgaard Pedersen as the company’s Head of Sales. In this role, Mr. Pedersen will oversee all commercial activities for the company as we continue to expand globally.“I am delighted to welcome a strong and experienced commercial leader like Erik to Glycorex. Erik brings extensive global commercial expertise to the organization from his work at companies like SSI Diagnostica, Euro Diagnostica AB (now Svar), DAKO and Olympus. He will continue to build the

BioStock: Chordate Medical’s CEO on the marketing and sales plans

2022 is expected to be a very important and exciting year for medtech company Chordate Medical, according to CEO Anders Weilandt's statement in the year-end report. The company is fully committed on pursuing the market plan for 2022, for both the migraine and the rhinitis treatments, but with stronger focus on migraine. They also aim to add one or more new markets during the year. BioStock contacted Weilandt to find out more about the marketing plans and his expectations for sales in 2022.Read the full article at biostock.se: https://www.biostock.se/en/2022/03/chordate-medicals-ceo-on-

Registration of capital increase of 4,479,204 shares in Penneo A/S completed

Company Announcement No. 7-2022Copenhagen, 7 March 2022 With reference to company announcement No. 6-2022, Penneo A/S ("Penneo") hereby announces that the capital increase of a nominal amount of DKK 89,584.08 consisting of 4,479,204 shares of a nominal value of DKK 0.02 each, representing approximately 16.5% of the share capital and the voting rights before the capital increase, has been registered with the Danish Business Authority. The new shares will be issued in the temporary ISIN code, DK0061681327, which will be merged with the primary ISIN code for existing shares,

#22-78  Correction of NGM Notice Financial Markets #22-77

Stressed market conditions on all equities and securitized derivatives A state of stressed market conditions has been decided for all equities and securitized derivatives. Stressed market conditions will remain until close of business as of March 7, 2022.When stressed market is called for, market makers are allowed to quote prices with a larger spread than normal. Please check our website www.ngm.se for information regarding the affected instruments. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@

#22-77 Stressed market conditions on all equities and securitized derivatives

A state of stressed market conditions has been decided for all equities and securitized derivatives. Stressed market conditions will remain until close of business as of March 1, 2022.When stressed market is called for, market makers are allowed to quote prices with a larger spread than normal. Please check our website www.ngm.se for information regarding the affected instruments. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM AB

Bio-Works signs distributor agreement with Brennan & Co for the Irish and Northern Irish markets

Bio-Works Technologies AB has signed a sole distributor agreement with Brennan & Co for both the Republic of Ireland and Northern Ireland. Under the terms of the agreement, Brennan & Co will market, sell and distribute WorkBeads, Bio-Works' next-generation protein purification products, to its customers. Brennan & Co thus have access to a competitive product catalogue for the purification of a wide range of biomolecules.“Through Brennan & Co, Bio-Works now has the opportunity to build closer relationships and offer local support to academic and biopharmaceutical customers across Ireland.

Viking Glory pendant is made from recycled gold in the vessel’s home port

The Åland-based goldsmith Maria Karlström designed a pendant specially for Viking Glory to commemorate the vessel’s christening. As is the tradition, the first person to wear the hand-forged gold jewellery, which depicts the sea surf and a lighthouse, was the vessel’s godmother, Isabel Lennse. A version of the Glory pendant made in silver is available for sale on board the new vessel.The christening of the vessel harks back to an earlier tradition: the godmother of a new vessel is given a piece of jewellery as a souvenir by the shipping company and the shipyard. Viking Line gave the Swede

Notice to Telia Company's Annual General Meeting 2022

The Annual General Meeting of Telia Company AB (publ), reg. no. 556103-4249, will be held on Wednesday, April 6, 2022. Due to COVID-19, the Board of Directors has decided that the Meeting is to be held only through postal voting in accordance with temporary legislation. It will not be possible to attend the Meeting in person or by way of a proxy holder.   Telia Company welcomes all shareholders to exercise their voting rights at the Meeting through postal voting. Information on the resolutions passed at the Meeting will be published on Wednesday, April 6, 2022, as soon as the result

Reminder: InDex Pharmaceuticals hosts Capital Markets Day on March 14, 2022

March 7, 2022 – InDex Pharmaceuticals Holding AB (publ) invites investors, analysts and media to a Capital Markets Day on March 14, 2022. The Capital Markets Day will be held in Krügersalen at Kapitel 8, Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm. The presentations will start at 15.00 CET with registration from 14.30 CET.The focus of the Capital Markets Day will be on the ongoing phase III study CONCLUDE with the drug candidate cobitolimod, cobitolimod's market potential and InDex’s long-term strategies for commercialisation of cobitolimod. Cobitolimod is under development as

Observe Medical ASA – Registration of share capital increase pertaining to the rights issue

7 March 2022: Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company ") on 24 February 2022, regarding the final result of the rights issue of 25,714,286 new shares in the Company (the "Offer Shares") at a subscription price of NOK 7.00 per Offer Share (the "Rights Issue"). The share capital increase pertaining to the Rights Issue has now been registered in the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company's new share capital is NOK 11,783,133.18 divided into 45,319,743 shares, each with a nominal value of

NIB signs 10-year loan to finance Viking Link interconnector

The Nordic Investment Bank (NIB) agrees a 10-year loan agreement with Danish TSO Energinet to increase the co-financing to construct the Viking Link, a 760- kilometre 1.4 GW high voltage direct current electricity interconnector between the substations of Revsing in southern Jutland in Denmark, and Bicker Fen in Lincolnshire, Great Britain.The DKK 1,500 million (EUR 201.67 million) loan will enable the more effective utilisation of renewable energy, access to sustainable electricity generation, and improve the security of electricity supplies. This is the second 10-year loan signed with

Automation supports large-scale production of green hydrogen

Semcon is supporting Norwegian Hystar to develop their new electrolyser technology for the production of green hydrogen. The aim is to produce up to 150% more hydrogen without using more energy than in conventional processes today.The project is now being expanded and Semcon is providing more expertise in order to automate the production of electrolyser stacks, which convert electricity to hydrogen and oxygen.Hydrogen production technology using PEM electrolysers is currently well developed, but advanced development of automatic and flexible stack production processes is required in order

Paulig withdraws from Russia

Paulig withdraws from Russia. The process will be done with due consideration to Paulig employees, customers, and local legislation. The process will start immediately and a detailed schedule is being evaluated.Russia and the surrounding countries is one of Paulig’s business areas and accounts for approximately 5% of the company’s revenue. Paulig has a coffee roastery in Tver, Russia, about 170 kilometers from Moscow. Its production is sold mainly in Russia. Paulig has approximately 200 employees in Russia. Further information: media@paulig.com About Paulig Paulig is a family-owned

There are no items matching the current filter
There are no more items matching the current filter
Back to top